Cited by 71Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsGenetic Associations and Epidemiology

APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos‐investigation of neurocognitive aging (HCHS/SOL)

Open access
Granot‐Hershkovitz, Einat, Tarraf, Wassim, Kurniansyah, Nuzulul, Daviglus, Martha, Isasi, Carmen R., Kaplan, Robert, Lamar, Melissa, Perreira, Krista M. +8 more·2021·Alzheimer's & Dementia

Abstract

Introduction: Apolipoprotein E ( APOE ) alleles are associated with cognitive decline, mild cognitive impairment (MCI), and Alzheimer's disease in Whites, but have weaker and inconsistent effects reported in Latinos. We hypothesized that this heterogeneity is due to ancestry‐specific genetic effects. Methods: We investigated the associations of the APOE alleles with significant cognitive decline and MCI in 4183 Latinos, stratified by six Latino backgrounds, and explored whether the proportion of continental genetic ancestry (European, African, and Amerindian) modifies these associations. Results: APOE ε4 was associated with an increased risk of significant cognitive decline (odds ratio [OR] = 1.15, P ‐value = 0.03), with the strongest association in Cubans (OR = 1.46, P ‐value = 0.007). APOE‐ ε2 was associated with decreased risk of MCI (OR = 0.37, P ‐value = 0.04) in Puerto Ricans. Amerindian genetic ancestry was found to protect from the risk conferred by APOE ε4 on significant cognitive decline. Discussion: Results suggest that APOE alleles' effects on cognitive outcomes differ across six Latino backgrounds and are modified by continental genetic ancestry.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.12205

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a study of 4,183 individuals from six Latino backgrounds, the effect of APOE-e4 on cognitive decline differed among groups.

    “They found that the effect of APOE‐e4 on cognitive decline differed among groups, suggesting that factors related to geographic background and genetic ancestry may alter the extent to which APOE‐e4 contributes to cognitive decline.”

    From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [96]

    The Methods (Study population) report 4,183 participants, and the Results examine six Latino background groups. The Results find a significant APOE ε4 association with cognitive decline only among Cubans, and an ancestry interaction, but tests of differences between groups were not significant. The Discussion treats a true difference in effect among groups as a possibility, so saying the study found such a difference overstates its evidence. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Factors related to geographic background and genetic ancestry may alter the extent to which APOE-e4 contributes to cognitive decline.

    “They found that the effect of APOE‐e4 on cognitive decline differed among groups, suggesting that factors related to geographic background and genetic ancestry may alter the extent to which APOE‐e4 contributes to cognitive decline.”

    From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [96]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [27]Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological Assessment, PsycNET. 4th ed. New York: Oxford University Press; 2004.

Cited by

Sorted by citations

Authors
Granot‐Hershkovitz, E., Tarraf, W., Kurniansyah, N., Daviglus, M., Isasi, C. R., Kaplan, R., Lamar, M., Perreira, K. M., Wassertheil‐Smoller, S., Stickel, A., Thyagarajan, B., Zeng, D., Fornage, M., DeCarli, C. S., González, H. M., & Sofer, T.
Affiliations
  • Brigham and Women's Hospital (US)
  • Wayne State University (US)
  • University of Illinois Chicago (US)
  • Albert Einstein College of Medicine (US)
  • Rush University Medical Center (US)
  • University of North Carolina at Chapel Hill (US)
  • Department of Epidemiology & Population Health Department of Pediatrics Albert Einstein College of Medicine Bronx New York USA
  • University of California San Diego (US)
  • University of Minnesota (US)
  • The University of Texas Health Science Center at Houston (US)
  • University of California, Davis (US)
Corresponding author
Sofer, Tamar
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2020-11-06
Volume
17
Issue
3
Pages
466-474
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W3095885963
Cited by
71
References
45
Citations by year
2026: 16 · 2025: 13 · 2024: 9 · 2023: 17 · 2022: 14 · 2021: 1 · 2020: 1
FWCI
6.02
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institute on Aging (R01AG048642, RF1AG054548, RF1AG061022, R21AG056952)
  • National Heart, Lung, and Blood Institute (HHSN268201300001I/N01‐HC‐65233)
  • University of Miami (HHSN268201300004I/N01‐HC‐65234)
  • Albert Einstein College of Medicine, Yeshiva University (HHSN268201300002I/N01‐HC‐65235)
  • University of Illinois at Chicago (HHSN268201300003I/N01‐HC‐65236)
  • San Diego State University (HHSN268201300005I/N01‐HC‐65237)
  • National Institute on Minority Health and Health Disparities
  • National Institute on Deafness and Other Communication Disorders
  • National Institute of Dental and Craniofacial Research (HHSN268201300005C AM03, MOD03)
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Neurological Disorders and Stroke
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
APOE alleles, APOE ε4
MeSH terms
Aged, Aging, Alleles, Alzheimer Disease, Cognition, Female, Genotype, Hispanic or Latino, Humans, Male, Middle Aged, Neuropsychological Tests, Prospective Studies, South America, United States, Caribbean Region, Apolipoprotein E4, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review